TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,081 | +1045.2% | 165,414 | +672.4% | 0.66% | +804.1% |
| Q1 2023 | $531 | -90.3% | 21,415 | -20.3% | 0.07% | -91.2% |
| Q4 2022 | $5,498 | -99.9% | 26,856 | -98.2% | 0.83% | -48.6% |
| Q3 2022 | $10,696,000 | +677.9% | 1,469,283 | +3015.0% | 1.62% | +562.0% |
| Q2 2022 | $1,375,000 | -70.7% | 47,168 | -5.5% | 0.24% | -68.1% |
| Q1 2022 | $4,690,000 | -3.3% | 49,926 | +1318.4% | 0.77% | -7.0% |
| Q4 2021 | $4,848,000 | -5.9% | 3,520 | -91.3% | 0.83% | +32.5% |
| Q3 2021 | $5,151,000 | +172.7% | 40,321 | +49.8% | 0.62% | +184.9% |
| Q2 2021 | $1,889,000 | +22.6% | 26,923 | -15.8% | 0.22% | -19.5% |
| Q1 2021 | $1,541,000 | -5.9% | 31,975 | +1.6% | 0.27% | +37.4% |
| Q4 2020 | $1,637,000 | – | 31,473 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |